Director
DIN: 08418349
Unmesh Shrikant Jere is currently associated with 2 companies in various capacities such as Additional Director and Director. They serve as a Director at MANCHESTER PHARMA PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08418349.Unmesh Shrikant Jere has previously been associated with 2 companies in roles such as Additional Director and Director.Unmesh Shrikant Jere is currently involved in 2 different roles. Their most recent position is with MANCHESTER LIFESCIENCES PRIVATE LIMITED as a Director. The first company Unmesh Shrikant Jere was appointed to as a director was MANCHESTER PHARMA PRIVATE LIMITED. Unmesh Shrikant Jere has a status of Deactivated. Please verify the details for any specific requirements or conditions.
Unmesh Shrikant Jere is currently associated with 2 companies in various capacities such as Additional Director and Director. They serve as a Director at MANCHESTER PHARMA PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08418349.Unmesh Shrikant Jere has previously been associated with 2 companies in roles such as Additional Director and Director.Unmesh Shrikant Jere is currently involved in 2 different roles. Their most recent position is with MANCHESTER LIFESCIENCES PRIVATE LIMITED as a Director. The first company Unmesh Shrikant Jere was appointed to as a director was MANCHESTER PHARMA PRIVATE LIMITED. Unmesh Shrikant Jere has a status of Deactivated. Please verify the details for any specific requirements or conditions.
2
Male
India
Call +91 81049 46419 and we'll pull the verified contact details for you.
Current Companies (2)
Current LLPs (0)
Past Companies (2)
1y 6m 9 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| MANCHESTER PHARMA PRIVATE LIMITED | Additional Director | 12-Apr-2019 |
| MANCHESTER LIFESCIENCES PRIVATE LIMITED | Director | 31-Dec-2020 |